Effect of occupational therapy home visit discharge planning on participation after stroke: Protocol for the HOME Rehab trial by Lannin, Natasha A. et al.
Edith Cowan University 
Research Online 
ECU Publications Post 2013 
2021 
Effect of occupational therapy home visit discharge planning on 
participation after stroke: Protocol for the HOME Rehab trial 




Edith Cowan University 
Leonid Churilov 
See next page for additional authors 
Follow this and additional works at: https://ro.ecu.edu.au/ecuworkspost2013 
 Part of the Public Health Commons 
10.1136/bmjopen-2020-044573 
Lannin, N. A., Clemson, L., Drummond, A., Stanley, M., Churilov, L., Laver, K., ... Cadilhac, D. A. (2021). Effect of 
occupational therapy home visit discharge planning on participation after stroke: Protocol for the HOME rehab trial. 
BMJ Open, 11(7), article e044573.https://bmjopen.bmj.com/content/11/7/e044573.abstract 
This Journal Article is posted at Research Online. 
https://ro.ecu.edu.au/ecuworkspost2013/10715 
Authors 
Natasha A. Lannin, Lindy Clemson, Avril Drummond, Mandy Stanley, Leonid Churilov, Kate Laver, Sophie 
O'Keefe, Ian Cameron, Maria Crotty, Tim Usherwood, Nadine E. Andrew, Laura Jolliffe, and Dominique A. 
Cadilhac 
This journal article is available at Research Online: https://ro.ecu.edu.au/ecuworkspost2013/10715 
1Lannin NA, et al. BMJ Open 2021;11:e044573. doi:10.1136/bmjopen-2020-044573
Open access 
Effect of occupational therapy home 
visit discharge planning on 
participation after stroke: protocol for 
the HOME Rehab trial
Natasha A Lannin   ,1,2 Lindy Clemson,3 Avril Drummond,4 Mandy Stanley   ,5 
Leonid Churilov,6,7 Kate Laver,8 Sophie O'Keefe,9 Ian Cameron,10 Maria Crotty,8,11 
Tim Usherwood,12,13 Nadine E Andrew   ,14,15 Laura Jolliffe,2,16 
Dominique A Cadilhac   15,17
To cite: Lannin NA, Clemson L, 
Drummond A, et al.  Effect of 
occupational therapy home 
visit discharge planning on 
participation after stroke: 
protocol for the HOME 
Rehab trial. BMJ Open 
2021;11:e044573. doi:10.1136/
bmjopen-2020-044573
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2020- 
044573).
Received 23 December 2020
Accepted 15 June 2021
For numbered affiliations see 
end of article.
Correspondence to
Dr Natasha A Lannin;  
 Natasha. Lannin@ monash. edu
Protocol
© Author(s) (or their 
employer(s)) 2021. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction After first stroke, the transition from 
rehabilitation to home can be confronting and fraught with 
challenges. Although stroke clinical practice guidelines 
recommend predischarge occupational therapy home 
visits to ensure safe discharge and provision of appropriate 
equipment, there is currently limited evidence to support 
this recommendation.
Methods and analysis The HOME Rehab trial is a 
national, multicentre, phase III randomised controlled 
trial with concealed allocation, blinded assessment and 
intention- to- treat analysis being conducted in Australia. 
The trial aim is to determine the effect and potential 
cost- effectiveness of an enhanced occupational therapy 
discharge planning intervention that involves pre and 
postdischarge home visits, goal setting and occupational 
therapy in the home (the HOME programme) in comparison 
to an in- hospital predischarge planning intervention. Stroke 
survivors aged ≥45 years, admitted to a rehabilitation 
ward, expected to return to a community (private) dwelling 
after discharge, with no significant prestroke disability 
will be randomly allocated 1:1 to receive a standardised 
discharge planning intervention and the HOME programme 
or the standardised discharge planning intervention alone. 
The primary outcome is participation measured using the 
Nottingham Extended Activities of Daily Living. Secondary 
outcome areas include hospital readmission, disability, 
performance of instrumental activities of daily living, 
health- related quality of life, quality of care transition and 
carer burden. Resources used/costs will be collected for 
the cost- effectiveness analysis and hospital readmission. 
Recruitment commenced in 2019. Allowing for potential 
attrition, 360 participants will be recruited to detect a 
clinically important treatment difference with 80% power 
at a two- tailed significance level of 0.05.
Ethics and dissemination This study is approved by 
the Alfred Health Human Research Ethics Committee 
and site- specific ethics approval has been obtained at 
all participating sites. Results of the main trial and the 
secondary endpoint of cost- effectiveness will be submitted 




Transitioning to home from hospital is 
a critical time for people poststroke.1–3 
Hospital- community communication and 
coordination can be inadequate during the 
discharge phase,4–6 increasing the risk of poor 
return to community activity, low satisfaction, 
adverse events and unplanned readmission. 
The most effective method for supporting 
hospitalised people who have experienced 
stroke to transition from hospital to home is 
not yet known7 8 which has led to variability in 
practice within the rehabilitation context.9 10
As a rehabilitation programme draws close 
to discharge, it is usual for people with stroke 
to be involved in discharge planning where 
they receive an occupational therapy predis-
charge home assessment. While it is recom-
mended in national clinical guidelines that 
occupational therapy predischarge home 
Strengths and limitations of this study
 ► The HOME Rehab trial will be conducted as a pow-
ered randomised controlled trial to measure the 
effect of adding an enhanced occupational therapy 
discharge planning intervention; it will provide cli-
nicians and hospital administrators with important 
information about supporting people with stroke to 
transition from hospital to home.
 ► This is a phase III trial with concealed allocation, 
blinded assessment and intention- to- treat analysis 
and includes a process evaluation and economic 
evaluation.
 ► The trial will be adequately powered to detect a clin-
ically important treatment difference in functional 
independence at 4- week postdischarge from hos-
pital after first stroke.
 ► Owing to the type of interventions, blinding of the 
participants and treatment providers is not possible.
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visits occur ‘to ensure safety and provision of appropriate 
aids, support and community services’,11 research to date 
suggests that there may not be any difference in outcomes 
for people who do and do not receive predischarge 
occupational therapy home visits.12–16 What remains 
unknown is whether a comprehensive discharge support 
programme that crosses the boundaries between hospital 
inpatient and community outpatient services may be 
more beneficial than usual care, which may lack coordi-
nation and effective communication. Therefore, we have 
designed the HOME Rehab trial to address this research 
gap.
The aim of this phase III randomised trial is to deter-
mine the clinical effect (disability, participation, instru-
mental activities of daily living), change in the number 
of unplanned readmissions and the potential cost- 
effectiveness of an enhanced occupational therapy 
discharge planning intervention that involves pre and 
postdischarge home visits, goal setting and occupational 
therapy in the home (the HOME programme) in compar-
ison to an in- hospital predischarge planning intervention. 
The specific research questions are:
1. In survivors of stroke, does the addition of the HOME 
programme to an in- hospital predischarge planning 
intervention improve activity participation at 4- week 
postdischarge (primary aim)?
2. Does it reduce unplanned hospital readmissions (sec-
ondary aim)?
3. Is it cost- effective (secondary aim)?
Primary end point is assessed at 4- weeks postdis-
charge; secondary aims, clinical outcomes and health 




The HOME Rehab trial is a multicentre, phase III 
randomised controlled trial being conducted in 
Australia with concealed allocation, blinded measure-
ment and intention- to- treat analysis. Adults who have 
experienced stroke will be recruited from inpatient reha-
bilitation wards across multiple states in Australia; the 
list of sites is available on the trial registry. Participants 
will be randomly allocated to receive in- hospital predis-
charge planning and the HOME programme or in- hos-
pital discharge planning alone. Clinical outcomes will be 
measured at baseline, 1- month (4- weeks) postdischarge 
(end of intervention) and 6 months postdischarge 
(beyond the intervention); health economic outcomes 
will be measured at 6 and 12 months postdischarge 
(figure 1). Measurements will be collected by assessors 
blind to group allocation. It is not possible to blind partic-
ipants or therapists to group allocation. The protocol has 
been approved by the relevant Human Research Ethics 
Committees and is registered at www. ANZCTR. org. au 
(ACTRN12618001360202).
Participants, therapists, sites
People with stroke will be included if they are aged 
≥45 years; admitted to a rehabilitation ward, which 
includes referral for occupational therapy; expected to 
return to live in a community (private) dwelling after 
discharge from hospital and have no significant prestroke 
disability (prestroke- modified Rankin Scale (mRS) score 
0–2). Participants will be excluded if they need major 
home modifications or receive daily assistance with all 
care so as to enable discharge, have severe comorbid 
disease (as assessed by a score <8 on the Charlson Comor-
bidity Index), have an illness likely to be associated with 
a life expectancy of <12 months, have a significant cogni-
tive impairment (>5 adjusted errors on the Short Portable 
Mental Status Questionnaire), have a body mass index of 
45 or higher, have moderate or severe aphasia or have a 
planned discharge to an address 2 hours or greater from 
a recruiting site.
Therapists will be eligible to deliver the intervention 
if they are occupational therapists with ≥3 years of expe-
rience and have completed training in the standardised 
delivery of the HOME programme.
Rehabilitation wards will be included if they have a 
stroke throughput of ≥20/year.
Randomisation and blinding procedure
Assessors will be blinded to treatment allocation. Partici-
pants will be randomly allocated to one of the two groups 
using a fixed allocation ratio of 1:1 following consent 
and baseline assessment. We anticipate that the response 
to both discharge programmes may be associated with 
pretreatment motor ability and whether their inpatient 
occupational therapist conducts the postdischarge visits, 
and so participants will be stratified by baseline Functional 
Figure 1 Design of the trial.
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Independence Measure (FIM)17 motor score (≤38 vs >38) 
and mode of delivery of occupational therapy (inpatient 
therapist vs community therapist) to minimise group 
imbalances on these variables. To maintain sequential 
recruitment balance between groups throughout the 
trial, a permuted block randomisation process will be 
used within each strata using random block sizes. The 
randomisation creation process (including block sizes) 
and resulting schedule will be set, held and managed 
centrally external to the investigators (LCh, The Univer-
sity of Melbourne) and will be managed using Research 
Electronic Data Capture (REDCap).18 19
Intervention
Participants in both groups (control and experimental) 
will undergo a standardised predischarge planning 
intervention led by an occupational therapist, and the 
experimental group will additionally receive the HOME 
programme.
This standardised in- hospital predischarge planning 
intervention will include one 30 minute in- hospital 
discharge planning assessment using the Discharge Plan-
ning Assessment Tool (DPAT)20 and a family- led home 
environment assessment. The DPAT is a client- centred 
assessment to prepare for discharge to a home environ-
ment; DPAT is to be completed by a client, significant 
other and occupational therapist and/or other team 
members early in hospitalisation and before discharge. 
The DPAT includes two rating scales of confidence (client 
and family member), and captures subscales related to 
returning home and managing care (including mobility 
in the home, mobility in the community, bathroom, 
bedroom, kitchen, household management, medication 
management, nutrition and diet, skin management and 
leisure). Results of the predischarge confidence and 
discharge plan evaluation (for participants in each group) 
will be shared with the inpatient rehabilitation team prior 
to discharge. The family- led home environment assess-
ment is a standardised checklist that is completed by the 
family, who are also loaned a tablet computer or digital 
camera to take photos of areas of the home that the 
participant would need or wish to access on return home. 
Using digital photographs taken by family members, 
patient information and an equipment list has previously 
been shown to be an accurate method of collecting neces-
sary information for occupational therapy home modifi-
cations/equipment prescriptions.21 22
In addition, participants will receive written instruc-
tions outlining their recommended home modifications 
and education for use of prescribed equipment prior to 
discharge.
Participants in the experimental group will then 
receive the HOME programme immediately following 
the standardised discharge planning intervention. Previ-
ously tested in an older, acute population,15 23 and piloted 
in general rehabilitation,16 the HOME programme is 
centred in the occupational therapy understanding that 
the interactions between a person and their environment 
drive meaningful participation in activity after hospital-
isation.24–26 The HOME programme commences during 
hospitalisation and dovetails with the standardised 
discharge planning intervention, but unlike the control 
intervention, the HOME programme continues posthos-
pitalisation (box 1). During hospitalisation, there is a focus 
on safety and transition from hospital, while posthospital-
isation, the focus is on increasing a person’s capacity to 
deal with demands from the environment and their newly 
acquired disability to maximise independence.
The experimental group will receive one predischarge 
(approximately 90 min) and two postdischarge visits by 
an occupational therapist, followed by two booster tele-
phone support sessions. Although performance gaps 
addressed are participant- specific (tailored), the process 
to identify and address the issues limiting independence 
and return to activity will be systematic and reproducible 
across all participants in the experimental group. Thus, 
all participants will receive identical intervention compo-
nents. While still in hospital, a predischarge home assess-
ment is conducted to assess the person- environment fit as 
well as observe the use of prescribed equipment in situ. 
Box 1 Clinical aims of the HOME occupational therapy 
programme
Prepare the person to return home and resume their desired 
lifestyle
 ► Assess the individual person’s occupational needs respecting their 
personal beliefs, needs and goals and understand the older person’s 
patterns of daily living.27 42
 ► Recommend functional adaptations that will maximise the person’s 
abilities as they reintegrate back to usual living.43
 ► Optimise the person- environment fit.44
 ► Recommend and implement environmental modifications.
 ► Prescribe adaptive equipment and observe its use in situ.42
 ► Facilitate effective communication between the individual person 
and their General Practitioner (GP) / health partners to support the 
transfer of medical information from hospital to community.28
Enhance self- efficacy beliefs and promote independence and 
sense of control through mastery of meaningful tasks
 ► Transfer altered skills to the home situation and assist in the adjust-
ment to these changes.45
 ► Habitual retraining in situ using strategies such as situational cues 
and targeting behaviours for change.
 ► Encourage one- on- one education about the safe performance of ac-
tivities in and around their home and immediate community.
 ► Facilitate joint problem- solving and solution generation.42 45
 ► Lessen a person’s fear during the transition from hospital to home.46
Use goal setting and motivational interviewing as therapeutic tools
 ► Develop client- centred goals that address individual occupational 
needs.27 42
 ► Develop goals that aim to maximise the person’s potential to partic-
ipate in meaningful activities.43
 ► Include goals that enable the person to participate in activities both 
in the home and in the community42 and incorporate primary health 
and physical activity goals.
 ► Plan for increasing independence/capacity postdischarge, setting 
goals for increasing activity.45 47
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Using the I- HOPE, activities that are valued but difficult 
to perform in the home environment will be identified 
and then prioritised, and the magnitude of the influence 
of the environment on performance of these activities 
will be assessed by the occupational therapist.27 Partici-
pation goals will then be set and results were shared with 
the inpatient rehabilitation team. These same I- HOPE 
goals will then shape the two postdischarge occupational 
therapy sessions with the aim of enhancing self- efficacy 
beliefs and promoting independence and the sense of 
control through mastery of meaningful activities. The 
two booster telephone support sessions will reinforce goal 
performance, enhance intrinsic motivation to return to 
activity28 and facilitate effective communication between 
the participant, family/carers and GP.29
Participants in the control group will receive only the 
standardised discharge planning intervention. Contami-
nation from the experimental intervention will be deter-
mined by examining the resource diary at the end of 
4- week intervention period, specifically to identify occu-
pational goals and interventions.
Primary outcome
Activity participation will be measured using the 
Nottingham Extended Activities of Daily Living 
(NEADL).30 The NEADL is a self- reported measure of 
22 activities representing four domains of daily living 
(mobility, kitchen, domestic and leisure) considered 
to be important to people with stroke who have been 
discharged home.
Secondary outcomes
 ► Quality of the care transition that is associated with 
hospitalisation will be assessed using the 3- item Care 
Transitions Measure,31 which is a validated measure 
reflecting the quality of a person’s care transition that 
is associated with hospital utilisation.
 ► Disability will be assessed by administering the 
mRS.32 33
 ► Functional ability will be assessed using the Functional 
Autonomy Measurement System,34 which measures in 
five areas: activities of daily living, mobility, communi-
cation, mental functions and instrumental activities of 
daily living.
 ► Health- related quality of life will be assessed using the 
EQ- 5D- 5L35 and will be used to also estimate quality- 
adjusted life years for the economic evaluation.
 ► Carer burden will be assessed using the Carer Experi-
ence Scale (CES).36 The CES focuses on six domains: 
activities outside caring, support from family and 
friends, assistance from the government and other 
organisations, fulfilment from caring, control over 
caring and getting on with the care recipient; this 
measure is administered to the carer.
Descriptive information will include demographic and 
socioeconomic information, details of the index stroke 
and prior health- related resource use (including occupa-
tional therapy). Date and cause of death will be obtained 
from linkages with the National Death Index held by the 
Australian Institute of Health and Welfare, including 
those who may be lost to follow- up at 6 months and 12 
months.
Economic evaluation
Direct costs for delivering each intervention over and 
above standard care (staff time and transportation, 
consumables and equipment), participant- related direct 
and indirect costs (participant time and transportation, 
change in employment status and impact of the interven-
tion on the activities of carers) and health system costs 
(ie, costs of health services used, readmissions) will be 
collected at each assessment time point and at 12 months. 
Hospital admissions (inclusive of emergency presenta-
tions and hospital admissions) will be collected from two 
sources at all timepoints, self- report by the participant 
and data obtained from hospital administrative data 
sets. Cost of each treatment pathway, resources used and 
their costs will be collected. Self- reported data related 
to health service utilisation and medications will be 
confirmed through person- level linkages of participant 
data with data held by state and commonwealth health 
departments. This will include the Pharmaceutical Bene-
fits Scheme and Medicare Benefits Schedule for the 12 
month period following discharge and a 12 month period 
prior to the index stroke event (to permit adjustment for 
prestroke utilisation trends that may be unrelated to the 
interventions being studied or unbalanced between the 
groups).
Data monitoring
Data safety and monitoring will be overseen by two health 
professionals and one statistician independent of the 
trial. The committee will review data related to safety and 
trial conduct within 3 months of enrolment of the first 
participant and then annually; an interim analysis will be 
undertaken at n=240. The committee will be responsible 
for stopping recruitment in the case of multiple serious, 
trial- related adverse events. For the purposes of this study, 
a serious adverse event will be defined as an event that 
(1) is fatal or life threatening, (2) results in persistent or 
significant disability or (3) results in hospitalisation. A 
nonserious adverse event would include such undesirable 
experiences such as noninjurious fall.
Patient and public involvement
Principles of the National Health and Medical Research 
Council Consumer and Community Involvement in 
Health and Medical Research statement37 have informed 
our approach to consumer and public engagement, with 
collaborative engagement with people with stroke, clini-
cians and policymakers from trial inception and design, 
to conduct and dissemination. This trial is supported by 
an end- user advisory panel, inclusive of advisors living 
with stroke, carers, occupational therapists, health 
managers and policymakers, who meet on a regular basis 
throughout the study. We will consult this panel to voice 
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end- user concerns, review process evaluation data and 
to identify end- user- oriented solutions to any concerns; 
multiple opportunities for involvement and feedback will 
be made available during the analyses around emergent 
concepts and trial implications to ensure engagement 
through to dissemination. Trial results will be interpreted 
by the end- user advisory panel, before a summary will be 
shared with participants who have indicated this to be 
their preference. All advisory panel members are paid an 
honorarium and will be thanked in the contributorship 
statement of any publications.
Process evaluation
The process evaluation plan was informed by the Medical 
Research Council Guidance on Process Evaluations of 
complex interventions38 and will focus on the evaluation 
of fidelity and implementation context. Intervention 
fidelity will be monitored throughout the study through 
annual site review with participating therapists to ensure 
that key components of the intervention are delivered, 
adherence to the protocol, and completeness of outcome 
assessments is maintained throughout the trial. Imple-
mentation will be explored using the RE- AIM (Reach, 
Effectiveness, Adoption, Implementation, and Mainte-
nance) framework39 components of Reach (measures of 
participant participation and representativeness) with 
collection of both quantitative and qualitative data to 
provide insights into the acceptance and burden from the 
perspectives of both participants and their carers; effec-
tiveness (success rate at an individual level); adoption 
(programme acceptance/uptake across the trial); imple-
mentation (fidelity of the programme to the protocolised 
intervention and factors which may potentially affect the 
trial outcome) and maintenance (long- term effects at 
the individual and organisational level) to both support 
explanation of trial findings and inform scale- up should 
the programme be effective.
Sample size estimates
Our pilot data demonstrated a mean change at 90 days 
postdischarge of 2.7 (SD 5.5) in activity participation 
measured by the NEADL in the home visit group and 0.8 
(0.5) in the control group. For the purposes of power 
analysis, we have hypothesised a potentially smaller but 
still clinically important effect, where the control group 
would exhibit a change score of 1 and a common SD of 
5.5. Recruitment of a total of n=330 (equally distributed 
between groups) would yield 80% power to detect such 
an effect using independent t- test with two- tailed alpha 
of 0.05. Allowing for potential attrition, the final total 
sample size of n=360 is adopted for this study. This sample 
size estimation is conservative, as in addition to the 
smaller hypothesised effect size, we would also expect an 
additional increase in power due to the inclusion of the 
baseline NEADL scores as a covariate in a corresponding 
analysis of covariance (ANCOVA) model prespecified for 
the primary analysis.
Once the outcomes for n=240 participants are 
obtained, an adaptive sample size estimation procedure 
will be undertaken as per the ‘promising zone’ method-
ology Mehta and Pocock40 with a potential increase in 
the total sample size to the prespecified maximum of 360 
participants.
Statistical analyses
All randomised participants will be included in the anal-
yses following intention- to- treat principles. Treatment 
of missing data will be based on the satisfiability of miss-
ingness at random assumptions and will be based on the 
intention- to- treat strategy as per White et al.41 Outcomes 
will be analysed using appropriate analysis of covariance 
or logistic regression models, controlling for baseline 
values, and presented as mean between- group differences 
(95% CI). For the primary outcome analysis, differences 
in mean change in NEADL (baseline minus follow- up) 
will be compared between groups using ANCOVA model 
with change as an outcome, treatment group as a factor 
and baseline value of NEADL as a covariate. The outcome 
will be presented as mean between- group difference with 
respective 95% CI. Effect of participant characteristics on 
outcomes will be explored by including relevant interac-
tion terms in regression models. The heterogeneity of 
effect across sites will be tested using respective mixed- 
effect models with individual centres as a random effect.
Similar adjusted analyses with appropriate regression 
models will be conducted for continuous secondary 
outcomes. Dichotomous secondary outcomes (ie, read-
mission) will be analysed using a logistic regression 
model with the readmission as the dependent variable 
and treatment group as independent variable, adjusted 
for relevant prespecified covariates. The outcomes will 
be presented as ORs with respective 95% CIs. Adjustment 
covariates will be prespecified in a separate Statistical 
Analysis Plan document that will provide the details of the 
analysis strategy prior to the lock of the trial data.
For the economic evaluation, there will be a cost descrip-
tion analysis of each treatment pathway and the incre-
mental difference for costs and quality- adjusted life years 
determined. A full economic evaluation protocol will be 
published prior to study recruitment being completed.
Study sponsorship and funding
The study is funded by the National Health and Medical 
Research Council, Australia, grant ID 1141561). Trial 
organisation, data management and monitoring are 
supported by Monash University, Melbourne, Australia.
DISCUSSION
The HOME trial will provide information that will assist 
survivors of stroke returning home after rehabilitation 
and their families, rehabilitation clinicians and policy-
makers make more informed decisions about the benefits 
of home assessments and postdischarge support for adults 
early after stroke. Findings will lead to evidence- based 
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clinical practise guideline recommendations, rather than 
expert opinion, allowing for clearer health policy, which 
in turn will improve outcomes for consumers and produce 
greater cost- efficiency in the rehabilitation sector.
The HOME Trial is the first prospective, randomised 
clinical trial to investigate the effect of adding an 
enhanced occupational therapy discharge planning inter-
vention that involves pre and postdischarge home visits, 
goal setting and occupational therapy in the home to an 
in- hospital predischarge planning intervention within a 
rehabilitation setting. The trial has concealed allocation, 
blinded assessment and intention- to- treat analysis and 
includes a process evaluation and economic evaluation.
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